Senior RWE Expert - WoCBA & Special Populations

UCB; Atlanta (GA); Hybrid; USD 164,000 - 215,000; Full time

Job summary

UCB is seeking a Senior RWE Expert to design and execute global real-world evidence projects across therapeutic areas. You will lead epidemiology, natural history, burden assessments, and data infrastructure development for WoCBA and other special populations, coordinating with internal teams and external partners.

The role emphasizes rigorous methods, innovative study designs, and clear communication of results to regulators, payers, and clinicians.

Qualifications

• Minimum Qualifications: Master’s Degree
• Experience successfully conceptualizing and delivering RWE projects using primary and secondary data
• 6 years of Global or regional experience
• Excellent and effective oral/written skills in English

Responsibilities

• EXECUTION of RWE STUDIES on time and to budget.
• input to / help drive the Global RWE Strategy & Tactical WoCBA/SPP Plan based on request from the RWE Strategy Lead responsible for the respective patient population/asset
• Leading Secondary Data Use Studies, including the most complex and high profile studies; and representing RWE on Primary Data Collection Study teams
• Collaborating with external vendors and medical experts on RWE projects, with BQS and RWE Analysts on the analysis plan
• Lead the interpretation of results and communicating results internally and externally
• Develop clearly defined evidence needs with the Evidence Synthesis group for HE/HTA and value communication plans

Skills

RWE study design

Epidemiology methods

Statistical analysis

Effective communication

Education

Master's Degree

PhD in epidemiology or related

Job description

UCB is seeking a Senior RWE Expert to design and execute global real-world evidence projects across therapeutic areas. You will lead epidemiology, natural history, burden assessments, and data infrastructure development for WoCBA and other special populations, coordinating with internal teams and external partners.

The role emphasizes rigorous methods, innovative study designs, and clear communication of results to regulators, payers, and clinicians.